Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Banzato

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Minerva Anestesiologica|May 9, 2013
Absent right superior vena cavaA Banzato, A Bianchi
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 1, 1993
Reversal of excessive effect of regular anticoagulation: low oral dose of phytonadione (vitamin K1) compared with warfarin discontinuationV Pengo, A Banzato, E Garelli, et al.
Giornale Di Stomatologia E Di Ortognatodonzia|July 1, 1989
[Organizational model for dental treatment of patients on antithrombotic prophylaxis with oral anticoagulants]M Berengo, V Pengo, P Peruzzi, et al.
Giornale Italiano Di Cardiologia|December 1, 1989
[Advantages of a cardiologic ambulatory care facility specifically organized for patients undergoing treatment with oral anticoagulant drugs]V Pengo, P Peruzzi, A Marzari, et al.
Platelets|March 8, 2017
The role of platelets in antiphospholipid syndromeG Baroni, A Banzato, E Bison, et al.
Lupus|April 1, 2010
Antiphospholipid syndrome: critical analysis of the diagnostic pathV Pengo, A Banzato, E Bison, et al.
Lupus|October 16, 2015
Efficacy and safety of rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome: Rationale and design of the Trial on Rivaroxaban in AntiPhospholipid Syndrome (TRAPS) trialV Pengo, A Banzato, E Bison, et al.
Giornale Italiano Di Cardiologia|July 1, 1995
[Revision and optimization of processes: a fundamental timing for adequate use of the resources and technological innovation. An example of intervention in the cardiology field and considerations on "total quality" in medicine]F Corbara, G Scattolin, A Gabellini, et al.
Autoimmunity Reviews|December 11, 2012
Correct laboratory approach to APS diagnosis and monitoringV Pengo, A Banzato, G Denas, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|January 9, 2001
Preferred conformation of peptides based on cycloaliphatic C(alpha,alpha)-disubstituted glycines: 1-amino-cycloundecane-1-carboxylic acid (Ac11c)M Saviano, R Iacovino, E Benedetti, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Minerva Anestesiologica|May 9, 2013
Absent right superior vena cavaA Banzato, A Bianchi
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 1, 1993
Reversal of excessive effect of regular anticoagulation: low oral dose of phytonadione (vitamin K1) compared with warfarin discontinuationV Pengo, A Banzato, E Garelli, et al.
Giornale Di Stomatologia E Di Ortognatodonzia|July 1, 1989
[Organizational model for dental treatment of patients on antithrombotic prophylaxis with oral anticoagulants]M Berengo, V Pengo, P Peruzzi, et al.
Giornale Italiano Di Cardiologia|December 1, 1989
[Advantages of a cardiologic ambulatory care facility specifically organized for patients undergoing treatment with oral anticoagulant drugs]V Pengo, P Peruzzi, A Marzari, et al.
Platelets|March 8, 2017
The role of platelets in antiphospholipid syndromeG Baroni, A Banzato, E Bison, et al.
Lupus|April 1, 2010
Antiphospholipid syndrome: critical analysis of the diagnostic pathV Pengo, A Banzato, E Bison, et al.
Lupus|October 16, 2015
Efficacy and safety of rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome: Rationale and design of the Trial on Rivaroxaban in AntiPhospholipid Syndrome (TRAPS) trialV Pengo, A Banzato, E Bison, et al.
Giornale Italiano Di Cardiologia|July 1, 1995
[Revision and optimization of processes: a fundamental timing for adequate use of the resources and technological innovation. An example of intervention in the cardiology field and considerations on "total quality" in medicine]F Corbara, G Scattolin, A Gabellini, et al.
Autoimmunity Reviews|December 11, 2012
Correct laboratory approach to APS diagnosis and monitoringV Pengo, A Banzato, G Denas, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|January 9, 2001
Preferred conformation of peptides based on cycloaliphatic C(alpha,alpha)-disubstituted glycines: 1-amino-cycloundecane-1-carboxylic acid (Ac11c)M Saviano, R Iacovino, E Benedetti, et al.
Pageof 4